Dermal Laboratories Limited

Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
Telephone: +44 (0)1462 458 866
Fax: +44 (0)1462 420 565
WWW: http://www.dermal.co.uk
Summary of Product Characteristics last updated on the eMC: 29/07/2009
SPC Salactol Collodion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   01-Apr-2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 9 (Renewal of the authorisation) the date has changed to "2 May 2006"
Updated on 11/09/2007 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   09/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.5 - Nature and contents of container - Addition of text 'This is supplied as an original pack (OP)'
Updated on 16/08/2007 and displayed until 11/09/2007
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
Date of revision of text on the SPC:   04/2007
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 1 - Name of the medicinal product:  Name has changed from "Salactol" to "Salactol Collodion"
Updated on 03/08/2004 and displayed until 16/08/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 29/01/2003 and displayed until 03/08/2004
Reasons for adding or updating:
  • Change to section 3 - pharmaceutical form
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 10 (date of (partial) revision of the text
Updated on 17/09/2002 and displayed until 29/01/2003
Reasons for adding or updating:
  • Change to section 4.3 - Contra-indications
  • Change to section 10 (date of (partial) revision of the text
Updated on 06/11/2001 and displayed until 17/09/2002
Reasons for adding or updating:
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.8 - Undesirable Effects
Updated on 23/07/2001 and displayed until 06/11/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 06/09/1999 and displayed until 23/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   salicylic acid
   lactic acid


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk